AMRX
Amneal Pharmaceuticals, Inc.
20.20$
+7.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.8% | 42.4% | 41.3% | 49.1% | 56.9% | 78.3% | 68.5% | 63.3% | 64.2% | 63.9% | 63.5% | 62.4% | |
| 57.2% | 57.6% | 58.7% | 50.9% | 43.1% | 21.7% | 31.5% | 36.7% | 35.8% | 36.1% | 36.5% | 37.6% | |
| 13.6% | 15.8% | 20.1% | 18.6% | 12.7% | 12.4% | 9.6% | 10.0% | 9.4% | 8.1% | 6.8% | 6.2% | |
| 10.8% | 23.2% | 11.7% | 10.5% | 13.9% | 17.8% | 16.4% | 17.5% | 17.3% | 17.4% | 15.8% | 17.5% | |
| 30.5% | 32.1% | 31.8% | 29.1% | 26.5% | 37.0% | 27.0% | 29.4% | 40.1% | 27.6% | 27.6% | 23.6% | |
| 28.4% | 26.2% | 28.0% | 23.7% | -1.2% | -15.3% | 4.6% | 7.3% | -4.3% | 8.5% | 8.9% | 14.0% | |
| 0.0% | 0.0% | 5.4% | 6.9% | 8.6% | 10.3% | 7.3% | 6.5% | 7.2% | 8.8% | 9.3% | 8.0% | |
| 22.8% | 20.3% | 21.1% | 16.6% | -12.2% | -13.5% | -1.8% | 1.5% | -11.2% | -1.7% | -2.0% | 4.6% | |
| 0.2% | 0.6% | 0.5% | 0.2% | -0.1% | 23.6% | -5.2% | 0.5% | 0.3% | 0.4% | 0.7% | 0.4% | |
| 22.5% | 19.6% | 20.4% | 16.2% | -10.2% | -22.3% | 4.6% | 0.5% | -5.9% | -3.5% | -4.2% | 2.4% | |
| 31.0% | 29.2% | 30.1% | 26.2% | -1.2% | 9.5% | 17.3% | 19.2% | 19.9% | 20.9% | 15.7% | 20.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.